A new study published in the journal of BMC Nephrology showed that in patients receiving peritoneal dialysis (PD), the ...

Oncoinvent ASA, a clinical stage company advancing alpha emitter therapy across a variety of solid cancers, today announced an interim data readout of the Phase 1/2a studies of Radspherin® for the ...

After Hurricane Helene struck Baxter's site in North Cove facility in Marion, N.C. — the nation's main manufacturer of intravenous and peritoneal dialysis solutions — several healthcare ...

The peritoneum has an area approximately that of the glomerular capillaries or of the twin-coil artificial kidney. Its behavior as an inert, semipermeable membrane and the use of "idealized ...

Hospitals want the Biden administration to shore up supplies of IV bags after a North Carolina factory closed from Hurricane ...

Oncoinvent ASA, a clinical stage company advancing alpha emitter therapy across a variety of solid cancers, announced an interim data readout of the phase 1/2a studies of Radspherin for the treatment ...

The company, which is a key producer for American healthcare providers, was hit by the hurricane when it tore through western ...

Baxter expects to restart a second IV solutions manufacturing line within the next week, the company announced Nov. 7. Along ...

Flooding from Hurricane Helene led to the damage and closure of a Baxter International manufacturing plant in North Carolina ...

RAD-18-002 is a Phase 1/2a open-label study designed to select the clinical dose, and evaluate the safety, tolerability, and signal of efficacy of intraperitoneally administered Radspherin® in ...

Clinical data update from the NXP800 Phase 1b study expected this month; NXP800 granted Orphan Drug Designation for the treatment of ...